E. Thiel
- Hematology top 2%
- Acute Myeloid Leukemia Research 22
- Chronic Myeloid Leukemia Treatments 13
- Hematopoietic Stem Cell Transplantation 9
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 20
- Gastroenterology top 5%
-
- Lymphoma Diagnosis and Treatment 13
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 29
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- CNS Lymphoma Diagnosis and Treatment 7
- Co-authors
- Stefan SchwartzUlrich KeilholzD. MilatovićThomas BurmeisterD. HoelzerAlexander SchmittelNicola GökbugetH. Rodt
- Cited by
- HematologyGeneticsGastroenterology
- Journals
- Journal of Clinical Oncology (13 papers)Blood (8 papers)International Journal of Oncology (5 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
E. Thiel
118 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 117
- Hematology 625
- Genetics 352
- Gastroenterology 137
- Pathology and Forensic Medicine 442
- Oncology 646
Countries citing papers authored by E. Thiel
This map shows the geographic impact of E. Thiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Thiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Thiel more than expected).
Fields of papers citing papers by E. Thiel
This network shows the impact of papers produced by E. Thiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Thiel. The network helps show where E. Thiel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Thiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 38 | |
| 2 | 2011 | 24 | |
| 3 | 2009 | 69 | |
| 4 | 2008 | 6 | |
| 5 | 2008 | 12 | |
| 6 | 2007 | 27 | |
| 7 | 2006 | 1 | |
| 8 | 2005 | 40 | |
| 9 | 2005 | 37 | |
| 10 | 2004 | 37 | |
| 11 | A prospective Multicenter study of the BMPD regimen with or without radiotherapy for primary CNS lymphoma. | 2003 | 1 |
| 12 | 2003 | 11 | |
| 13 | 2002 | 18 | |
| 14 | 2000 | 8 | |
| 15 | 2000 | 18 | |
| 16 | 1997 | 21 | |
| 17 | 1995 | 17 | |
| 18 | Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas. | 1994 | 5 |
| 19 | 1993 | 22 | |
| 20 | 1990 | 2 |
About E. Thiel
E. Thiel is a scholar working on Hematology, Genetics and Immunology, having authored 121 papers that have together received 2.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (29 papers), Acute Myeloid Leukemia Research (22 papers), Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Chronic Myeloid Leukemia Treatments (13 papers), Hematopoietic Stem Cell Transplantation (9 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (625 citations), Genetics (352 citations) and Gastroenterology (137 citations). E. Thiel has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Stefan Schwartz, Ulrich Keilholz, D. Milatović, Thomas Burmeister, D. Hoelzer, Alexander Schmittel, Nicola Gökbuget, H. Rodt, S Daum and S. Thierfelder. Their work appears in journals such as Journal of Clinical Oncology, Blood, International Journal of Oncology, British Journal of Haematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.